Antihypertensive drug
Losartan, an antihypertensive drug
... Losartan, (I), is an antihypertensive drug, characterized as an angiotensin II receptor antagonist (FernaÂndez et al., 2002, and references therein). Earlier structure determinations of this compound relate ...
9
ANTIHYPERTENSIVE DRUG UTILIZATION IN PATIENT ATTENDING PRIVATE MEDICAL CENTER IN INDIA
... The study was conducted in Sarvahit Medical Center, (MH) India from January 2009 to June 2009. Total 700 prescriptions were studied and evaluated for six months as per WHO Guideline. Analysis of prescription data reveals ...
7
Antihypertensive drug treatment changes in the general population: the colaus study
... all antihypertensive drugs were collected and coded using the Anatomical Therapeutic Chemical (ATC) classification system ...follow-up, antihypertensive drugs were classified into six different categories: ...
9
Formulation and Evaluation of Orally Disintegrating Tablets of Antihypertensive Drug Naftopidil
... Orally disintegrating tablet is a promising approach with a view of obtaining faster action of the drug and would be advantageous in comparison to currently available conventional forms. The dosage form had a good ...
8
FABRICATION DEVELOPMENT, OPTIMIZATION AND CHARACTERIZATION OF GASTRORETENTIVE MICROSPHERES OF AN ANTIHYPERTENSIVE DRUG
... antihypertensive drug. It has mean plasma half-life of 2-3 hour and only 40 % of the drug reaches to the systemic circulation due to hepatic first pass ...and drug release were also ...
5
FORMULATION DEVELOPMENT AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS WITH ANTIHYPERTENSIVE DRUG
... in antihypertensive therapy. Clonidine was the first antihypertensive drug developed in the transdermal ...of antihypertensive transdermal patches are introduced in to the pharmaceutical ...
10
TRANSDERMAL PATCH OF AN ANTIHYPERTENSIVE DRUG: ITS DEVELOPMENT AND EVALUATION
... Hypertensive is a disease characterized by persistently high blood pressure. Hypertension is one of the largest deaths causing disease for the human being. Since it is a chronic disease so it necessitates long term ...
20
FORMULATION & EVALUATION OF OPTIMISED CHRONO RELEASE OF ANTIHYPERTENSIVE DRUG
... The drug is also indicated in prophylactic treatment of ...plasma drug level, resulting either in manifestation of side effect or reduction in drug concentration at the receptor ...pulsatile ...
7
FORMULATION AND CHARACTERIZATION OF MOUTH DISINTEGRATING TABLET CONTAINING ANTIHYPERTENSIVE DRUG
... Different types of dosage forms i.e tablets, capsules, suspensions, emulsions, syrups, aerosols etc. are available to treat various pathological and emergency conditions. The era belongs to morden technology and new ...
14
Formulation, Optimization and Evaluation of Bilayer Tablet of Antihypertensive Drug
... Hypertension or high blood pressure occurs when the high cardiac output exerts pressure on the arterial wall as the blood flow increases. Bi- layer tablets are prepared with one layer of drug for immediate release ...
5
Evaluation of the rationality of some FDCs: Focus on antihypertensive drug
... development of an ADR, it is difficult to withdraw the suspected drug alone. Therefore, the risk-benefit assessment is essential before choosing a combination for therapy. The FDCs are of value only when they have ...
5
FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF AN ANTIHYPERTENSIVE DRUG
... In-vitro drug release study was performed up to 600 seconds. In-vitro drug release studies showed that drug get rapidly released from all ...percentage drug release and time and shown in ...
12
New Easily Swallowed Tablets with Slippery Coating for the Antihypertensive Drug Valsartan
... affecting drug release (immediate release) and doesn’t disintegrate in the mouth (un-like ODTs) with an acceptable taste masking ...for drug and dose selection and lower taste masking difficulties than ...
11
Buccal Mucoadhesive Films Containing Antihypertensive Drug: In vitro/in vivo Evaluation
... Although the oral administration of drugs has been the preferred route of administration for the patients and clinicians, certain disadvantages such as hepatic first pass metabolism, gastric irritation, and enzymatic ...
22
DEVELOPMENT AND EVALUATION OF TRANSDERMAL THERAPEUTIC SYSTEM OF AN ANTIHYPERTENSIVE DRUG
... of drug delivery that has been used for a long time and continue to overwhelm the novel drug delivery system even today have forced the biologists to look for the alternatives beyond the ...of drug ...
6
FORMULATION AND EVALUATION OF MULTI LAYER MATRIX TABLETS OF ANTIHYPERTENSIVE DRUG CAPTOPRIL
... provision of constant rate input and maintenance of steady state blood levels. The pharmacokinetic studies have established that it has relatively short half life of 1.7 – 1.9 h and 70% of oral bioavilability.It is ...
14
Design and development of osmotically controlled drug delivery system for antihypertensive drug.
... novel drug delivery systems ...available drug particle can be obtaining a novel life there by, growing its marketplace worth, competitiveness in addition to patent ...
170
NOVEL MULTIPARTICULATE DRUG DELIVERY SYSTEM OF CARVEDILOL AS ANTIHYPERTENSIVE DRUG
... The layering stage includes depositing of successive layering of active entities from suspension or solution on nuclei (pellets of inert material/sugar spheres). Solution layering includes depositing of respective layers ...
7
BIOEQUIVALENCE AND BIOAVAILABILITY STUDY OF ANTIHYPERTENSIVE DRUG: A REVIEW
... Hydrochlorothiazide appears to be a potent diuretic as well as antihypertensive agent. Its main action is to produce sodium and chloride diuresis. Ten patients with essential hypertension and one with congestive ...
10
SOLUBILITY ENHANCEMENT, FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET OF ANTIHYPERTENSIVE DRUG TADALAFIL
... Stability study: The optimized formulation was wrapped in aluminium foil and subjected to 40 ±2°C temperature and 75± 5% RH in oven for the period of three months. The formulation was analyzed for organoleptic ...
9